Earnings Feed
Start Free
NEOGENOMICS INC·4

Jun 4, 4:08 PM ET

KANOVSKY STEPHEN M 4

4 · NEOGENOMICS INC · Filed Jun 4, 2024

Insider Transaction Report

Form 4
Period: 2024-06-01
NEOGENOMICS INCNEO
KANOVSKY STEPHEN M
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-01+8,672→ 8,672 total
    Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying)
  • Award

    Restricted Stock Unit

    2024-06-01+12,254→ 12,254 total
    Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
    4,269

  • Stock Option (Right to Buy)

    Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
    3,448

  • Stock Option (Right to Buy)

    Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying)
    3,714

  • Common Stock

    24,754

  • Stock Option (Right to Buy)

    Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying)
    8,353

  • Stock Option (Right to Buy)

    Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying)
    13,882

  • Restricted Stock Unit

    Exercise: $0.00From: 2024-08-10→ Common Stock (11,336 underlying)
    11,336
Footnotes (1)
  • [F1]Once vested, the shares of common stock are not subject to expiration.

Documents

1 file
  • 4
    wk-form4_1717531712.xmlPrimary

    FORM 4